Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
XDA Developers on MSN
My productivity stack was overwhelming, here's how I made it manageable
The most underrated software feature I've encountered recently is automated scheduling based on completion date. Many apps ...
XDA Developers on MSN
My non-negotiable self-hosted productivity stack for 2026
Joplin doesn’t chase trends. No AI noise, no bloated features. It quietly does the job of being a reliable second brain, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback